VCM
ROIV icon

Versant Capital Management’s Roivant Sciences ROIV Stock Holding History

Versant Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$150K Buy
4,113
+118
+3% +$4.28K 0.01% 748
2026
Q2 		$141K Buy
3,995
+487
+14% +$14.4K 0.01% 767
2026
Q1 		$97.2K Buy
3,508
+53
+2% +$1.36K 0.01% 876
2025
Q4 		$75K Buy
3,455
+27
+0.8% +$533 0.01% 882
2025
Q3 		$51.9K Hold
3,428
– – 0.01% 1018
2025
Q2 		$38.6K Buy
3,428
+1,323
+63% +$14.3K 0.01% 1126
2025
Q1 		$21.2K Buy
2,105
+1,898
+917% +$20.5K ﹤0.01% 1318
2024
Q4 		$2.45K Buy
+207
New +$2.45K ﹤0.01% 2006
2024
Q3 		– Sell
-257
Closed -$2.72K – 2070
2024
Q2 		$2.72K Buy
+257
New +$2.82K ﹤0.01% 1425

Other funds holding ROIV

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
FFAS
FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return
LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Versant Capital Management's ROIV Position: Q3 2026 in Review

Versant Capital Management increased its Roivant Sciences (ROIV) stake by 3% in Q3 2026, buying an estimated $4.28K and bringing the position to 4,113 shares worth $150K. The position accounts for 0.01% of the portfolio, ranked #748.

Versant Capital Management first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. 20 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Versant Capital Management held 4,113 shares of Roivant Sciences worth $150K as of Q3 2026.
  • Versant Capital Management bought 118 Roivant Sciences shares in Q3 2026, an estimated $4.28K.
  • Roivant Sciences made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #748 holding.
  • Versant Capital Management first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
  • 20 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.